323
Participants
Start Date
December 21, 2018
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Vehicle
Vehicle, one drop in each eye, once daily, for up to 30 days.
Pilocarpine HCl Ophthalmic Solution
Pilocarpine HCl ophthalmic solution 1.25%, one drop in each eye, once daily, for up to 30 days.
Alterman, Modi & Wolter, Poughkeepsie
Rochester Ophthalmological Group, PC, Rochester
Scott & Christie and Associates, PC, Cranberry Township
Seidenberg Protzko Eye Associates, Havre de Grace
Mundorf Eye Center, Charlotte
Florida Eye Associates, Melbourne
Direct Helpers Research Center, Hialeah
Research Centers of America, Hollywood
Bruce Segal, MD, Delray Beach
USF Eye Institute, Tampa
The Eye Associates, Bradenton
Nashville Vision Associates, Nashville
Southern College of Optometry, Memphis
The Eye Care Institute, Louisville
EyeCare Professionals DWA Insight Research Clinic, LLC, Powell
The Ohio State University, Columbus
Price Vision Group, Indianapolis
Vance Thompson Vision, Sioux Falls
Black Hills Regional Eye Institute, Rapid City
Tauber Eye Center, Kansas City
Sabates Eye Centers, Leawood
Key-Whitman Eye Center, Dallas
PNV Clinical Research LLC, San Antonio
R and R Eye Research, LLC, San Antonio
Hill Country Eye Center, Cedar Park
Haas Vision Center, Colorado Springs
Hoopes, Durrie, Rivera Research, Draper
Arizona Eye Center, Chandler
Schwartz Laser Eye Center, Scottsdale
American Institute of Research, Los Angeles
Assil Eye Institute, Beverly Hills
Eye Research Foundation, Newport Beach
Martel Eye Medical Group, Rancho Cordova
Grutzmacher & Lewis, A Medical Corporation DBA Sacramento Eye Consultants, Sacramento
Devers Eye Institute, Portland
Danbury Eye Physicians and Surgeons P.C., Danbury
Lead Sponsor
Allergan
INDUSTRY